Jounce Therapeutics Inc (JNCE):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Jounce Therapeutics Inc (JNCE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8273
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:44
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Jounce Therapeutics Inc (Jounce) is a clinical stage immunotherapy company that develops therapies that enable the immune system to attack tumors. The company provides JTX-2011, an anti-ICOS monoclonal antibody which stimulates T effector cells to enhance anti-tumor activity; JTX-4014, an anti-PD-1 antibody for combination therapy in tumor eradication. It harnesses its proprietary product engine to gain new insights into cancer immunotherapy and explore multiple mechanisms of action against a broad spectrum of targets. Jounce offers services in the areas of tumor immunology, antibody discovery and optimization and integrated translational capabilities. The company has collaborations with the universities, general hospitals and cancer centers. Jounce is headquartered in Cambridge, Massachusetts, the US.

Jounce Therapeutics Inc (JNCE) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Jounce Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Jounce Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Jounce Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Jounce Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Jounce Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9
Jounce Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Jounce Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Jounce Therapeutics Raises USD56 Million in Series B Financing 11
Jounce Therapeutics Raises US$47 Million In Series A Financing 13
Partnerships 14
OncoSec Medical Enters into Agreement with Jounce Therapeutics 14
Celgene Enters into Agreement with Jounce Therapeutics 15
Jounce Therapeutics Enters Into Research Agreement With Adimab 16
Licensing Agreements 17
Jounce Therapeutics Exercises Option for Licensing Agreement with Adimab 17
Jounce Therapeutics Amends Licensing Agreement for JTX-2011 18
Equity Offering 20
Jounce Therapeutics Files Registration Statement to Raise up to USD250 Million in Public Offering of Securities 20
Jounce Therapeutics Files Registration Statement to Raise up to USD280.7 Million in Public Offering of Shares 21
Jounce Therapeutics Raises USD117.12 million in IPO 22
Jounce Therapeutics Raises USD139 Million in Private Placement of Shares 24
Jounce Therapeutics Inc – Key Competitors 25
Jounce Therapeutics Inc – Key Employees 26
Jounce Therapeutics Inc – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Recent Developments 28
Financial Announcements 28
Aug 09, 2018: Jounce Therapeutics reports second quarter 2018 financial results 28
May 09, 2018: Jounce Therapeutics Reports First Quarter 2018 Financial Results 30
Mar 08, 2018: Jounce Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results 31
Nov 13, 2017: Jounce Therapeutics Reports Third Quarter 2017 Financial Results 33
Aug 09, 2017: Jounce Therapeutics Reports Second Quarter 2017 Financial Results 34
May 09, 2017: Jounce Therapeutics Reports First Quarter 2017 Financial Results 36
Mar 10, 2017: Jounce Therapeutics reports net income for Q4, provides fiscal 2017 guidance 38
Mar 10, 2017: Jounce Therapeutics reports net income for Q4 39
Corporate Communications 40
Dec 14, 2017: Jounce Therapeutics Added to NASDAQ Biotechnology Index 40
Oct 23, 2017: Jounce Therapeutics Appoints Luis A. Diaz, Jr., M.D., to its Board of Directors 41
Aug 15, 2017: Jounce Therapeutics Names Hugh Cole as Chief Business Officer and Head of Corporate Development 42
Mar 31, 2017: Jounce Therapeutics Added to Russell 2000, 3000 and Microcap Indexes 43
Appendix 44
Methodology 44
About GlobalData 44
Contact Us 44
Disclaimer 44

List of Tables
Jounce Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Jounce Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Jounce Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Jounce Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Jounce Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Jounce Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9
Jounce Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Jounce Therapeutics Raises USD56 Million in Series B Financing 11
Jounce Therapeutics Raises US$47 Million In Series A Financing 13
OncoSec Medical Enters into Agreement with Jounce Therapeutics 14
Celgene Enters into Agreement with Jounce Therapeutics 15
Jounce Therapeutics Enters Into Research Agreement With Adimab 16
Jounce Therapeutics Exercises Option for Licensing Agreement with Adimab 17
Jounce Therapeutics Amends Licensing Agreement for JTX-2011 18
Jounce Therapeutics Files Registration Statement to Raise up to USD250 Million in Public Offering of Securities 20
Jounce Therapeutics Files Registration Statement to Raise up to USD280.7 Million in Public Offering of Shares 21
Jounce Therapeutics Raises USD117.12 million in IPO 22
Jounce Therapeutics Raises USD139 Million in Private Placement of Shares 24
Jounce Therapeutics Inc, Key Competitors 25
Jounce Therapeutics Inc, Key Employees 26
Jounce Therapeutics Inc, Subsidiaries 27

List of Figures
Jounce Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Jounce Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Jounce Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Jounce Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Jounce Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Jounce Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Jounce Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Jounce Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Jounce Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Jounce Therapeutics Inc (JNCE):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Active Biotech AB (ACTI):製薬・医療:M&Aディール及び事業提携情報
    Summary Active Biotech AB (Active Biotech) is a biotechnology company that develops and commercializes pharmaceuticals in the field of inflammatory/neurodegenerative diseases and cancer. The company’s key products in development include Laquinimod (neurodegenerative diseases); Anyara (cancer); Tasqu …
  • Cymbet Corp:電力:M&Aディール及び事業提携情報
    Summary Cymbet Corp (Cymbet) is a clean technology company that offers energy storage solutions for microelectronic systems. The company’s products include EnerChip, EnerChip solid state batteries, EnerChip bare die, EnerChip RTC and evaluation kits. Its devices offers new concept in energy storage …
  • AEON Co Ltd (8267):企業の戦略的SWOT分析
    AEON Co Ltd (8267) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Imugene Ltd (IMU):製薬・医療:M&Aディール及び事業提携情報
    Summary Imugene Ltd (Imugene) is a clinical stage biopharmaceutical company which researches and develops vaccines in the area of immune-oncology. The company focuses on developing immunotherapies for the treatment of HER-2+ gastric and breast cancer. The HER-2 receptor works on surface of various t …
  • Lincoln Electric System:発電所・企業SWOT分析
    Lincoln Electric System - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key emplo …
  • WebMD Health Corp:企業の戦略的SWOT分析
    WebMD Health Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • SAP SE (SAP):企業の財務・戦略的SWOT分析
    SAP SE (SAP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • Samson Oil & Gas Ltd (SSN):石油・ガス:M&Aディール及び事業提携情報
    Summary Samson Oil & Gas Limited (Samson) is engaged in the acquisition, exploitation, exploration and development of oil and natural gas properties in the US. It is also engaged in producing natural gas liquids. The company’s projects include Foreman Butte project, which is located in Williston Bas …
  • Pon Holdings BV:企業の戦略・SWOT・財務情報
    Pon Holdings BV - Strategy, SWOT and Corporate Finance Report Summary Pon Holdings BV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • HUGO BOSS AG:企業の戦略・SWOT・財務情報
    HUGO BOSS AG - Strategy, SWOT and Corporate Finance Report Summary HUGO BOSS AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Xhale Inc:製品パイプライン分析
    Summary Xhale Inc (Xhale) is a medical technology company that develops and commercializes patient-centric monitoring solutions for the healthcare industry. The company offers platforms such as SMART and assurance platforms. Its products include therapeutic drug monitoring, metabolic pathway assessm …
  • Corbion NV (CRBN):企業の財務・戦略的SWOT分析
    Corbion NV (CRBN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Invuity Inc (IVTY)-医療機器分野:企業M&A・提携分析
    Summary Invuity Inc (Invuity) is a medical technology company that offers visualization products for the less invasive surgical procedures. The company offers handhelds, retractors and drop-ins. Its handhelds products include saber frazier and saber yankauer. Invuity offers retractors such as breite …
  • A. O. Smith Corporation:企業の戦略・SWOT・財務情報
    A. O. Smith Corporation - Strategy, SWOT and Corporate Finance Report Summary A. O. Smith Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Hollister Inc:企業の戦略的SWOT分析
    Hollister Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Roche Diagnostics International Ltd-医療機器分野:企業M&A・提携分析
    Summary Roche Diagnostics International Ltd (Roche Diagnostics) offers novel diagnostic tests and systems for the early identification, targeted screening, assessment and monitoring of diseases. Its major products include point-of-care testing devices; analyzers, blood glucose meters; laboratory inf …
  • Paradigm Biopharmaceuticals Ltd (PAR):製薬・医療:M&Aディール及び事業提携情報
    Summary Paradigm Biopharmaceuticals Ltd (Paradigm Biopharma) is a biopharmaceutical company. The company focused on research and development of therapeutic products for human use. It offers pentosan polysulphate sodium (PPS) drugs for new orthopaedic and respiratory applications. Paradigm Biopharma …
  • CareDx Inc (CDNA):企業の財務・戦略的SWOT分析
    Summary CareDx Inc (CareDx) formerly XDx Inc, is a molecular diagnostics company focused on the discovery, development, and commercialization of diagnostic solutions for transplant patients. The company offers products which include AlloMap, a noninvasive blood test used by clinicians to monitor and …
  • Cofidis Participations S.A.
    Cofidis Participations S.A. - Strategy, SWOT and Corporate Finance Report Summary Cofidis Participations S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Curemark LLC-医療機器分野:企業M&A・提携分析
    Summary Curemark LLC (Curemark) is a biopharmaceutical company that offers development of novel therapies. The company develops novel therapies to treat serious diseases for which there are limited treatment options. It provides CM-AT, CM-4612, CM-PK, CM-182, and CM-1212 drugs. Curemark’s product ca …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆